Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Prospective Real-life Observational Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

NCT07029126 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor.

NCT NCT07029126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07029126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Prospective Real-life Observational Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
Lead sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Phase
Observational
Overall status
Completed
Start date
October 3, 2024
Completion date
March 30, 2026
Enrollment
308 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

migraine